Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial-Reference-Cited by-同舟云学术

Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial

Published:2022-01 Issue:1 Volume:207 Page:61-69
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Chevli K. Kent¹,Shore Neal D.²,Trainer Andrew³,Smith Angela B.⁴,Saltzstein Daniel⁵,Ehrlich Yaron⁶,Raman Jay D.⁷,Friedman Boris⁸,D’Anna Richard⁹,Morris David¹⁰,Hu Brian¹¹,Tyson Mark¹²,Sankin Alexander¹³,Kates Max¹⁴,Linehan Jennifer¹⁵,Scherr Douglas¹⁶,Kester Steven¹⁷,Verni Michael¹⁸,Chamie Karim¹⁹,Karsh Lawrence²⁰,Cinman Arnold²¹,Meads Andrew²²,Lahiri Soumi²²,Malinowski Madlen²²,Gabai Nimrod²²,Raju Sunil²²,Schoenberg Mark¹³²²,Seltzer Elyse²²,Huang William C.²³^ORCID

Affiliation:

1. State University of New York at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York

2. Atlantic Urology Clinics, Carolina Urologic Research Center, Myrtle Beach, South Carolina

3. Adult Paediatrics Urology & Urogynecology, Omaha, Nebraska

4. University of North Carolina School of Medicine, Chapel Hill, North Carolina

5. Urology San Antonio, San Antonio, Texas

6. Rabin Medical Center, Petah-Tikva, Israel

7. Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania

8. Lady Davis Carmel Medical Center, Technicon–Israel Institute of Technology, Haifa, Israel

9. Arkansas Urology, Little Rock, Arkansas

10. Urology Associates, Nashville, Tennessee

11. Loma Linda University, Loma Linda, California

12. Mayo Clinic, Scottsdale, Arizona

13. Albert Einstein College of Medicine, Bronx, New York

14. Brady Urological Institute, Johns Hopkins Medicine, Baltimore, Maryland

15. John Wayne Cancer Institute, Santa Monica, California

16. Weill Medical College of Cornell University, New York, New York

17. Urology Center of Florida, Pompano Beach, Florida

18. Urology Center of Las Vegas, Las Vegas, Nevada

19. UCLA, Los Angeles, California

20. The Urology Center of Colorado, Denver, Colorado

21. Tower Urology, Los Angeles, California

22. UroGen Pharma, New York, New York

23. NYU Langone Urology Associates, New York, New York

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Local Drug Delivery in Bladder Cancer: Advances of Nano/Micro/Macro-Scale Drug Delivery Systems;Pharmaceutics;2023-12-03

2. Re: DaBlaCa-13 Study: Oncological Outcome of Short-term, Intensive Chemoresection with Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a Randomized Controlled Trial;European Urology;2023-11

3. Novel Delivery Mechanisms for Existing Systemic Agents and Emerging Therapies in Bladder Cancer;Bladder Cancer;2023-06-27

4. Injectable Thermoresponsive Hydrogels for Cancer Therapy: Challenges and Prospects;Gels;2023-05-16

5. Risk Stratification of Nonmuscle Invasive Bladder Cancer and Innovative Approaches to Management of Ta Low-Grade Tumors;Journal of Clinical Oncology;2023-01-10